Angiosarcoma of the scalp treated with OK-432 and rIL-2.
Miura
Hiroyuki
H
Department of Dermatology, Graduate School of Medicine, Osaka University, Japan. kanrou@mac.com
Inui
Sigeki
S
Sakai
Hiroshi
H
Hasebe
Nobushige
N
Itami
Satoshi
S
Yoshikawa
Kunihiko
K
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006394:Hemangiosarcoma / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D010844:Picibanil / Q000008:administration & dosage / Q000627:therapeutic use*; D011995:Recombination, Genetic; D012535:Scalp / Q000187:drug effects* / Q000473:pathology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000970:Antineoplastic Agents; D007376:Interleukin-2; D010844:Picibanil